Magazine article Drug Topics

...And for the Lady?

Magazine article Drug Topics

...And for the Lady?

Article excerpt

The prayers of men suffering from impotence have recently been answered with the approval of Pfizer's orally administered Viagra (sildenafil). But has the other half of the population been left out of the blessing? Maybe not. While sildenafil, a phosphodiesterase type 5 inhibitor, is set to undergo testing in women suffering from the frustrations of sexual dysfunction, another agent is also under investigation. Developed by Harvard Scientific Corp., a lyophilized liposomal prostaglandin E-1 (LLPGE1) formula is believed to stimulate the production of vaginal fluid and increase blood flow to the area, thereby providing adequate lubrication for sexual intercourse and heightened sensation. Older women and those with vascular problems have been reported to suffer from such complications as vaginal dryness-leading to discomfort during intercourse-and diminished clitoral sensation.

Loony tune

Sing the right tune and you may demolish a few cancer cells. Perhaps that is oversimplified, but it's the principle behind a new cancer treatment proposed by Israeli researchers. Just as an opera singer could shatter a glass with a high-pitched note, a sound-at a resonant frequency unique to cancer cells- could cause severe destructive vibrations exclusively in the neoplastic cells.

The theory is based on the fact that frequencies at which an object will vibrate are determined by structural properties of that object. And because the internal structural components of cancer cells differ from those of healthy cells, the two types of cells should vibrate and ultimately succumb to different frequencies. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.